1 / 7

Blood Screening Market

The global blood screening market is expected to reach USD 2.80 Billion by 2021 from USD 1.76 Billion in 2016, at a CAGR of 9.7% from 2016 to 2021

poonam26
Download Presentation

Blood Screening Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MarketsandMarkets Presents  Blood Screening Market Size, By Technology, 2014–2021 http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html

  2. The report "Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021"The global blood screening market is expected to reach USD 2.80 Billion by 2021 from USD 1.76 Billion in 2016, at a CAGR of 9.7% from 2016 to 2021 Browse 97 market data tables and 39 figures spread through 150 pages and in-depth TOC on “Blood Screening Market” http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html Early buyers will receive 10% customization on this report. The major factors driving the growth of this market are increasing number of blood donations and blood donors, growing affordability and adoption of nucleic acid amplification test (NAT) for blood screening, rising awareness regarding the safety of donated blood, growing demand for donated blood, and increasing prevalence/incidence of infectious diseases. http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html .

  3. Blood screening is a medical process in which donated blood is mainly tested for HIV1, HIV2, HBV, HCV, malaria, syphilis, and various other infectious diseases. Donated blood is screened for these infectious diseases to reduce the risk of transfusion-transmitted infections (TTIs). Download PDF Broacher : http://www.marketsandmarkets.com/pdfdownload.asp?id=267747042 This report segments the blood screening market on the basis of technology, product & service, end user, and region Based on technology, the market is segmented into NAT, ELISA, rapid tests, western blot assays, and NGS. The NAT segment is further subsegmented into TMA and real-time PCR. The ELISA technology segment is further categorized into various generations and platforms. On the basis of generation, the ELISA segment is further divided into first generation ELISA, second generation ELISA, third generation ELISA, and fourth & above generation ELISA. . http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html

  4. On the basis of product and service, the blood screening market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment is further subsegmented into NAT, ELISA, and other reagents and kits. The instrument segment is categorized based on purchase mode and is further subsegmented into rental purchase and outright purchase. Download Sample Pages of this Report@ http://www.marketsandmarkets.com/requestsample.asp?id=267747042 On the basis of end user, the blood screening market is segmented into blood banks and hospitals. The blood banks segment is expected to account for the largest share of the market in 2016. Major factors driving the growth of this segment are the increasing demand for donated blood, growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, increasing number of donations worldwide, and growth in government funding to charitable trusts. http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html

  5. On the basis of region, the blood screening market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Growth in this regional segment is driven by factors such as increasing adoption of nucleic acid tests (NAT) and increasing participation of various government associations in blood donations and screening & transfusion activities . Key players in the blood screening market include Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Siemens Healthineers (Germany), Abbott Laboratories (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Dickinson and Company (U.S.), and Beckman Coulter, Inc. (U.S.). http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html

  6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.  httphttp://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html

  7. Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.comMarketsandMarkets Bloghttp://www.marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets

More Related